Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital
<b>Background</b>: Our aim was to examine the frequency and prescription pattern of breakthrough (BTO) and scheduled (SCH) opioids and their ratio (BTO/SCH ratio) of use, prior to and after referral to an inpatient supportive care consult (SCC) for cancer pain management (CPM). <b>...
Main Authors: | Aline Rozman de Moraes, Elif Erdogan, Ahsan Azhar, Suresh K. Reddy, Zhanni Lu, Joshua A. Geller, David Mill Graves, Michal J. Kubiak, Janet L. Williams, Jimin Wu, Eduardo Bruera, Sriram Yennurajalingam |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/31/3/101 |
Similar Items
-
The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain
by: Sebastiano Mercadante, et al.
Published: (2021-03-01) -
Breakthrough pain and rapid-onset opioids in patients with cancer pain: a narrative review
by: Jinseok Yeo
Published: (2024-01-01) -
A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study
by: Sebastiano Mercadante, et al.
Published: (2021-05-01) -
Rapid-Onset Opioids for Management of Breakthrough Cancer Pain: Considerations for Daily Practice
by: Paolo Bossi, et al.
Published: (2022-05-01) -
Once again... breakthrough cancer pain: an updated overview
by: Sebastiano Mercadante
Published: (2023-07-01)